Author | Physical function | Pain | Spinal mobility | Spinal stiffness | Patient’s global assessment | Peripheral joints/entheses | Acute phase reactants | Spine/hip radiograph | Fatigue |
---|---|---|---|---|---|---|---|---|---|
SM-ARD trials | |||||||||
Dougados (1994) [41] | +,+ (DFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | − | − | − | −/− | − |
Dougados (1999) [42] | +,+ (DFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | − | +,+ (CRP) | −/− | − |
Dougados (2001) [43] | +,+ (BASFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | − | +,+ (CRP) | −/− | − |
Van der Heijde (2005_2) [44] | +,+ (BASFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | +,+ (BASDAI question 4) | +,+ (CRP) | −/− | − |
Barkhuizen (2006) [27] | +,+ (BASFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | − | +,+ (CRP) | −/− | − |
Physical therapy trials | |||||||||
Kraag (1990) [45] | +,+ (TADLQ) | +,+ (VAS) | +,+ (Schober) | +,+ (TADLQ) | − | − | − | −/− | − |
Hidding (1993) [46] | +,+ (DFI 0) | +,+ (VAS) | +,+ (Schober) | +,+ (VAS) | +,+ (VAS) | +,+ (enthesitis index) | − | −/− | − |
Helliwell [31] | − | +,+/− (VAS) | +,+ (Schober) | +,+/− (VAS) | − | − | − | −/− | − |
Van Tubergen (2001) [47] | +,+ (BASFI) | +,+ (VAS) | − | +,+ (minutes) | +,+ (VAS) | − | − | −/− | − |
Sweeney (2002) [48] | +,+ (BASFI) | +,+ (SES) | − | − | +,+ (BAS-G) | − | − | −/− | − |
Analay (2003) [49] | +,+ (BASFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | − | − | − | −/− | − |
Codish (2005) [50] | +,+ (BASFI) | +,+ (VAS) | +,+/− (Schober) | − | − | − | − | −/− | − |
Fernandez-de-Las-Penas (2005) [51] | +,+ (BASFI) | − | +,+ (Schober) | − | − | − | − | −/− | − |
Lim [30] | +,+ (BASFI) | +,+/− (VAS) | +,+ (FFD) | − | − | − | − | −/− | − |
Ince (2006) [52] | − | − | +,+ (Schober) | − | − | − | − | −/− | − |
Altan (2006) [53] | +,+ (BASFI) | +,+ (VAS) | +,+ (Schober) | +,+ (NRS) | +,+ (NRS) | − | − | −/− | − |
DC-ART trials | |||||||||
Dougados (1986) [54] | +,+ (DFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | − | +,+ (enthesitis index) | +,+ (ESR) | −/− | − |
Feltelius [28] | − | +,+/− (VAS) | +,+/− (Schober) | +,+ (VAS) | +,+ (VAS) | +,+ (enthesitis index) | +,+ (ESR) | −/− | − |
Nissila (1988) [55] | − | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | +,+ (22-joint count) | +,+ (CRP) | −/− | − |
Davis (1989) [56] | − | +,+ (VAS) | +,+ (occiput-to-wall distance) | +,+ (VAS) | − | − | +,+ (CRP) | −/− | − |
Winkler (1989) [57] | − | +,+ (VAS) | +,+ (Schober) | +,+ (hours) | +,+ (VAS) | +,+ (66-joint count) | +,+ (ESR) | −/− | − |
Corkill [58] | − | +,+ (VAS) | +,+ (occiput-to-wall distance) | +,+ (VAS) | − | − | +,+ (CRP) | −/− | − |
Krajnc (1990) [59] | − | − | +,+ (Schober) | − | − | − | −/− | − | |
Taylor [34] | − | +,+ (VAS) | +,+ (Schober) | +,+ (VAS) | +,+/− (NRS) | +,+/− (joint count) | +,+ (CRP) | +,+/− SIJ score | − |
Kirwan [29] | +,− (HAQ) | +,− (VAS) | +,+ (Schober) | +,+/− (VAS) | +,– (VAS) | +,+/− (44-joint count) | − | −/− | − |
Clegg (1996) [60] | +,+ (DFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | +,+/− (NRS) | +,+ (44-joint count) | +,+ (CRP) | −/− | − |
Altan [35] | +,+ (DFI) | +,+ (VAS) | +,− (Schober) | +,+ (minutes) | +,+ (NRS) | +,+ (enthesitis index) | +,+ (CRP) | −/− | − |
Braun [36] | +,+ (BASFI) | +,+/− (NRS) | +,+ (BASMI) | +,+/− (minutes) | +,+ (NRS) | +,+ (44-joint count) | +,+ (CRP) | −/− | +,+/− (NRS) |
Gorman (2002) [61] | +,+ (BASFI) | +,+/− (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | +,+ (66-joint count) | +,+ (CRP) | −/− | − |
Roychowdhury (2002) [62] | − | − | +,+ (BASMI) | +,+ (minutes) | − | − | +,+ (CRP) | −/− | − |
Schmidt (2002) [63] | +,+ (DFI) | +,+ (VAS) | +,+ (Schober) | +,+ (minutes) | − | +,+ (enthesitis index) | +,+ (CRP) | −/− | − |
Brandt [37] | +,+ (BASFI) | +,+/− (NRS) | +,+ (BASMI) | +,+/− (NRS) | − | +,+/− (66-joint count) | +,+/− (CRP) | −/− | +,+/− (NRS) |
Davis (2003) [64] | +,+ (BASFI) | +,+/− (VAS) | +,+ (Schober) | +,+ (minutes) | +,+ (VAS) | +,– (68-joint count) | +,+ (CRP) | −/− | − |
Calin (2004) [65] | +,+ (BASFI 0) | +,+ (VAS) | +,+ (BASMI) | +,+ (minutes) | +,+ (VAS) | +,– (68-joint count) | +,+ (CRP) | −/− | +,+ (VAS) |
Gonzalez-Lopez [38] | +,+ (BASFI) | +,+ (VAS) | − | +,+ (VAS) | +,+ (VAS) | +,+ (44-joint count) | +,− (ESR) | −/− | − |
Marzo-Ortega (2005) [66] | +,+ (BASFI) | +,+ (VAS) | − | +,+ (minutes) | − | +,+ (enthesitis index) | +,− (ESR) | −/− | − |
Van der Heijde (2005_1) [44] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | − | +,+ (VAS) | +,+ (enthesitis Index) | +,+ (CRP) | −/− | − |
Van der Heijde [32] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | +,+ (VAS) | +,+ (VAS) | +,+ (44-joint count) | +,+ (CRP) | −/− | − |
Van der Heijde (2006_2) [67] | +,+ (BASFI) | +,+ (VAS) | +,+ (Schober) | +,+ (VAS) | +,+ (VAS) | +,+ (70-joint count) | +,+ (CRP) | −/− | − |
Lambert (2007) [68] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | +,+ (VAS) | +,+ (VAS) | +,+ (44-joint count) | +,+ (CRP) | −/− | − |
Inman (2008) [69] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | +,+ (VAS) | +,+ (VAS) | − | +,+ (CRP) | −/− | +,+ (JESQ) |
Barkham (2010) [70] | +,+ (BASFI) | − | − | +,+ (VAS) | − | − | – | −/− | − |
Inman (2010) [71] | +,+ (BASFI) | − | +,+ (BASMI) | − | +,+ (BAS-G) | − | +,+ (CRP) | −/− | − |
Braun (2011) [72] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | +,+/− (VAS) | +,+ (VAS) | +,+ (66-joint count) | +,+ (CRP) | −/− | − |
Dougados [39] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | − | +,− (VAS) | − | +,+ (CRP) | −/− | − |
Navarro-Sarabia (2011) [73] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | − | +,+ (VAS) | +,+ (66-joint count) | +,+ (CRP) | −/− | +,+/− (VAS) |
Hu [40] | +,+ (BASFI) | +,+ (VAS) | − | − | − | − | +,+ (CRP) | −/− | +,+/− (VAS 0–10) |
Bao (2014) [74] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | − | − | − | +,+ (CRP) | −/− | +,+ (JESQ) |
Huang (2014) [75] | +,+ (BASFI) | +,+ (VAS) | +,+ (BASMI) | +,+ (VAS) | +,+ (VAS) | +,+ (44-joint count) | +,+ (CRP) | −/− | – |